Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Research|October 19, 2007
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progressionStephanie K Bunt, Linglin Yang, Pratima Sinha, et al.Cancer Research|March 18, 2004
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic diseaseErika A Danna, Pratima Sinha, Mileka Gilbert, et al.Journal of Leukocyte Biology|December 24, 2016
Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in miceSuzanne Ostrand-Rosenberg, Pratima Sinha, Chas Figley, et al.Blood|April 1, 2011
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasLPratima Sinha, Olesya Chornoguz, Virginia K Clements, et al.Journal of Leukocyte Biology|January 19, 2018
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cellsVirginia K Clements, Tiha Long, Ramses Long, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependentSuzanne Ostrand-Rosenberg, Virginia K Clements, Masaki Terabe, et al.Cancer Immunology, Immunotherapy : CII|August 29, 2007
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytesJames A Thompson, Minu K Srivastava, Jacobus J Bosch, et al.Cancer Research|August 29, 2014
HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cellsKatherine H Parker, Pratima Sinha, Lucas A Horn, et al.Journal of Proteome Research|November 16, 2017
Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive FunctionsLucía Geis-Asteggiante, Ashton T Belew, Virginia K Clements, et al.Cancer Research|March 5, 2004
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapySamudra K Dissanayake, James A Thompson, Jacobus J Bosch, et al.Pageof 3